Purchases and Sales Made in Q3 2024 in Nephros Inc (NEPH)
This table provides information about the institutional ownership of Nephros Inc (NEPH) during Q3 2024. The information is specifically focused on institutions that hold shares of NEPHROS INC.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 13, 2024
Q3 2024
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
7.97K+ 4.11% |
$13.6K - $18.3K
|
202K
$303K
|
|
|
Nov 12, 2024
Q3 2024
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
7.21K+ 9.24% |
$12.3K - $16.5K
|
85.2K
$128K
|
|
|
Nov 14, 2024
Q3 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
5.39K+ 45.48% |
$9.21K - $12.3K
|
17.2K
$25.9K
|
|
|
Nov 13, 2024
Q3 2024
|
Elkhorn Partners Limited Partnership
Omaha, NE |
BUY
|
- |
441+ 1.23% |
$754 - $1.01K
|
36.4K
$54.7K
|
|
|
Nov 14, 2024
Q3 2024
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
20+ 26.32% |
$34.2 - $45.8
|
96
$144
|
|
|
Oct 10, 2024
Q3 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Dec 26, 2024
Q3 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-1- 0.45% |
$1.71 - $2.29
|
221
$332
|
|
|
Nov 08, 2024
Q3 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-1- 0.45% |
$1.71 - $2.29
|
221
$332
|
|
|
Nov 14, 2024
Q3 2024
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-882- 24.01% |
$1.51K - $2.02K
|
2.79K
$4.19K
|
|
|
Nov 07, 2024
Q3 2024
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-2.76K- 15.63% |
$4.71K - $6.31K
|
14.9K
$22.3K
|
|
|
Nov 06, 2024
Q3 2024
|
Bard Associates Inc
Chicago, IL |
SELL
|
- |
-3.23K- 1.84% |
$5.51K - $7.39K
|
172K
$259K
|
|
|
Nov 13, 2024
Q3 2024
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-16.6K- 40.38% |
$28.3K - $37.9K
|
24.4K
$36.7K
|
|
|
Nov 14, 2024
Q3 2024
|
Ubs Group Ag
|
SELL
|
- |
-19.2K- 99.37% |
$32.9K - $44.1K
|
121
$182
|